Home Cart Sign in  
Chemical Structure| 153773-82-1 Chemical Structure| 153773-82-1

Structure of Ertapenem sodium
CAS No.: 153773-82-1

Chemical Structure| 153773-82-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ertapenem sodium is a broad-spectrum β-lactam antibiotic with high efficacy against various Gram-positive and Gram-negative bacteria. Ertapenem sodium is mainly used in research on the treatment of severe bacterial infections.

Synonyms: L-749345; MK-826

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ertapenem sodium

CAS No. :153773-82-1
Formula : C22H24N3NaO7S
M.W : 497.50
SMILES Code : O=C(C(N12)=C(S[C@@H]3CN[C@H](C(NC4=CC=CC(C(O)=O)=C4)=O)C3)[C@H](C)[C@]2([H])[C@@H]([C@H](O)C)C1=O)[O-].[Na+]
Synonyms :
L-749345; MK-826
MDL No. :MFCD09475566

Safety of Ertapenem sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H317
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
M. tuberculosis H37Rv 0.6 ml/liter Assess the MIC of ertapenem in a hollow-fiber model, showing a lower MIC value Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01489-18
Clinical strains of M. tuberculosis 16 mg/liter (single agent), 4 mg/liter (with clavulanate) Evaluate the in vitro activity of ertapenem against M. tuberculosis, showing reduced MIC when combined with clavulanate Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01489-18
MRSA MW2 4 mg/liter Evaluate the synergy between ertapenem and cefazolin against MRSA MW2, showing static activity when the two drugs were used in combination. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6609-6618
E. coli NDM-1 64 mg/liter 24 hours Determine the minimum inhibitory concentration (MIC) of ertapenem Antimicrob Agents Chemother. 2020 Jul 22;64(8):e00853-20
E. coli KPC-3 8 mg/liter 24 hours Determine the minimum inhibitory concentration (MIC) of ertapenem Antimicrob Agents Chemother. 2020 Jul 22;64(8):e00853-20
E. coli OXA-48 0.5 mg/liter 24 hours Determine the minimum inhibitory concentration (MIC) of ertapenem Antimicrob Agents Chemother. 2020 Jul 22;64(8):e00853-20
E. coli CFT073 0.008 mg/liter 24 hours Determine the minimum inhibitory concentration (MIC) of ertapenem Antimicrob Agents Chemother. 2020 Jul 22;64(8):e00853-20

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice (Mus musculus) Lethal sepsis model induced by cecal ligation and puncture (CLP) 30 mg/kg 30 minutes, 6 hours, and 12 hours/12 hours for 3 days To evaluate the effects of ertapenem alone or in combination with the lipid fraction of Agaricus brasiliensis (LF) on survival, clinical parameters, inflammation, and oxidative stress in septic mice. Results showed that ertapenem alone had a survival rate of 33.3%, while combined with LF, survival increased to 100%. Antioxidants (Basel). 2024 Jul 30;13(8):927
Mice Cecal ligation and puncture (CLP)-induced sepsis model Intraperitoneal injection 70 mg/kg Every 24 hours until the end of the experiment To evaluate the effect of antibiotic treatment on cardiac function and survival in septic mice. Results showed that ertapenem treatment partially restored cardiac function, increased cardiac output, and reduced mortality. J Am Heart Assoc. 2019 May 21;8(10):e012260
C57BL/6 mice Cecal ligation and puncture (CLP)-induced sepsis model Intraperitoneal injection 70 mg/kg Once daily for three days To evaluate the effect of combined treatment with ertapenem and LGM2605 on survival and body temperature in septic mice, results showed combined treatment significantly improved survival and reversed hypothermia. J Mol Cell Cardiol. 2019 Feb;127:232-245
ICR mice Neutropenic murine complicated urinary tract infection model Subcutaneous injection 1 g q24h Every 24 hours for 48 hours Evaluate the antibacterial efficacy of ertapenem against ESBL-producing E. coli, showing ≥2 log kill over 48 hours Antimicrob Agents Chemother. 2017 Oct 24;61(11):e01329-17
Mice C. rodentium and S. Typhimurium infection models Crystallization experiment 1 mM Single treatment To resolve the structure of YcbB and understand its interaction with ertapenem Antimicrob Agents Chemother. 2021 Jan 20;65(2):e01592-20
Swiss mice TB infection model 100 mg/kg once daily Once daily for 28 days Evaluate the in vivo activity of ertapenem in a TB-infected mouse model, showing no bactericidal or bacteriostatic effect Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01489-18
ICR mice Neutropenic murine pneumonia model Subcutaneous injection 15 sequential doses ranging from 85 to 5 mg/kg over the 24 h dosing period 24 hours To evaluate the in vivo efficacy of WCK 6777 against carbapenemase-producing Klebsiella pneumoniae. Results showed that the WCK 6777 HSR regimen produced kill in 18 out of 21 isolates tested, exceeding the translational benchmark for efficacy of a 1 log10 cfu reduction. J Antimicrob Chemother. 2022 Jun 29;77(7):1931-1937
CD1 mice Subcutaneous infection model Intraperitoneal injection 0.5 mg ETP (20 mg/kg body weight) Every 8 hours for 3 doses Evaluate the efficacy of ertapenem and cefazolin combination therapy in a MSSA subcutaneous infection model, showing significant reduction in bacterial counts in tissue compared to control. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6609-6618
Swiss ICR mice Lethal peritonitis model Subcutaneous injection 100 mg/kg Every 6 hours for 24 hours Evaluate the in vivo efficacy of ertapenem against carbapenemase-producing E. coli, results showed ertapenem significantly reduced bacterial counts in spleen and peritoneal fluid and prevented mortality Antimicrob Agents Chemother. 2020 Jul 22;64(8):e00853-20

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.01mL

0.40mL

0.20mL

10.05mL

2.01mL

1.01mL

20.10mL

4.02mL

2.01mL

References

 

Historical Records

Categories